CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nimbus Therapeutics, a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, today announced the appointment of Erin Cowhig as Chief People Officer. In this newly created role, Ms. Cowhig will oversee all aspects of Nimbus’ human resources, talent acquisition and management, and diversity and inclusion efforts.
“Our people are the reason for Nimbus’ many years of success. With Erin’s leadership as Chief People Officer we are excited to further build our high-performing team, continuing to recruit talented and diverse new Nimbi, develop and invest in our people, and foster a values-driven culture,” said Jeb Keiper, M.S., MBA, Chief Executive Officer of Nimbus. “We’re very excited to welcome Erin to the Nimbus team and are confident that her deep experience in human resources, talent acquisition, and diversity and inclusion will contribute to driving Nimbus’ future success.”
Prior to joining Nimbus, Ms. Cowhig was Vice President, Human Resources at Vertex Pharmaceuticals, where she was responsible for HR governance, portfolio management, and organizational effectiveness as well as serving on Vertex’s HR leadership team. Ms. Cowhig was also responsible for leading Vertex’s Diversity and Inclusion strategy. Prior to Vertex, Ms. Cowhig was Senior Director and Head of Talent at Agios Pharmaceuticals, where she led talent acquisition and talent management efforts amidst the company’s transition from a research-focused organization to a late-stage development and commercial company. Ms. Cowhig holds a B.S. (Read more…) in human development and a Master of Industrial and Labor Relations, both from Cornell University.
“Nimbus’ community of passionate, talented people is an incredible asset, and it’s a team I feel privileged to join,” said Ms. Cowhig. “I’m excited to build upon the people-centric culture Nimbus has created to continue to make Nimbus a place of diverse, engaged, top-notch people who are empowered to do their best work and to make a difference in the lives of patients.”
About Nimbus Therapeutics
Nimbus Therapeutics designs breakthrough medicines. Utilizing its powerful structure-based drug discovery engine, Nimbus designs potent and selective small molecule compounds targeting proteins that are known to be fundamental drivers of pathology in highly prevalent human diseases and which have proven difficult for other drug makers to tackle. The company’s LLC/subsidiary architecture enables diverse and synergistic partnerships to deliver breakthrough medicines. Nimbus is headquartered in Cambridge, Mass. www.nimbustx.com.
Contacts
Lisa Raffensperger, (617) 903-8783
Ten Bridge Communications
lisa@tenbridgecommunications.com